Search Results

You are looking at 11 - 20 of 56 items for :

  • "pituitary adenoma" x
Clear All
Open access

Anastasia P Athanasoulia-Kaspar, Matthias K Auer, Günter K Stalla and Mira Jakovcevski

length might be linked to the increased morbidity and mortality observed for both diseases ( 16 , 17 ). To the best of our knowledge, studies examining the TL in patients with non-functioning pituitary adenomas (NFPA), characterized by a high incidence

Open access

Morten Winkler Møller, Marianne Skovsager Andersen, Christian Bonde Pedersen, Bjarne Winther Kristensen and Frantz Rom Poulsen

Introduction Pituitary adenomas (PAs) account for 10–25% of intracranial tumors ( 1 , 2 , 3 ). They arise from adenohypophyseal cells, despite their benign nature, 25–55% of PAs show invasive growth ( 4 ), expanding into suprasellar ( 5

Open access

Kush Dev Singh Jarial, Anil Bhansali, Vivek Gupta, Paramjeet Singh, Kanchan K Mukherjee, Akhilesh Sharma, Rakesh K Vashishtha, Suja P Sukumar, Naresh Sachdeva and Rama Walia

to stimulation), sensitivity for lateralization of pituitary adenoma during BIPSS was 22/27; and 16/22 of patients had accurate lateralization of the ACTH source. Post-stimulation during BIPSS, 27/27 patients lateralized pituitary adenoma with any of

Open access

Julie M Silverstein

Introduction Acromegaly is a rare hormonal condition that develops most commonly from benign somatotroph pituitary adenomas and has a prevalence of 36–69 cases per million and an incidence of 3–4 cases per million per year (1, 2, 3, 4) . However

Open access

Emmanuelle Motte, Anya Rothenbuhler, Stephan Gaillard, Najiba Lahlou, Cécile Teinturier, Régis Coutant and Agnès Linglart

Introduction Cushing’s disease (CD) is characterized by adrenocorticotropin (ACTH)-dependent cortisol excess originating from a pituitary adenoma and accounts for approximately 85% of cases of pediatric Cushing’s syndrome ( 1 , 2 , 3 , 4

Open access

Nidan Qiao

Acromegaly Parameters from 3D shape of face Acromegaly/healthy 24:25 SVM (linear or quadratic kernel) Acc: 85.7% LOOCV NA Kitajima 2009 (7) 43 Sellar mass Age and 9 MRI features Pituitary adenoma/craniopharyngioma/Rathke’s cyst

Open access

Nadine M Vaninetti, David B Clarke, Deborah A Zwicker, Churn-Ern Yip, Barna Tugwell, Steve Doucette, Chris Theriault, Khaled Aldahmani and Syed Ali Imran

the following inclusion criteria: i) seen between January 1, 2006, and June 30, 2014; ii) have any of the following diagnoses: non-functioning pituitary adenoma (NFA), prolactinoma (PRLoma), growth hormone-producing adenoma (GH adenoma

Open access

G Giuffrida, F Ferraù, R Laudicella, O R Cotta, E Messina, F Granata, F F Angileri, A Vento, A Alibrandi, S Baldari and S Cannavò

Local Ethical Committee of Messina. The first patient (female, 58 years old), with giant prolactin (PRL)-secreting pituitary adenoma (prolactinoma), received five cycles of 111 In-DTPA-octreotide (total activity 37 GBq) from July 2009 to June 2011

Open access

Eva Jakobsson Ung, Ann-Charlotte Olofsson, Ida Björkman, Tobias Hallén, Daniel S Olsson, Oskar Ragnarsson, Thomas Skoglund, Sofie Jakobsson and Gudmundur Johannsson

Introduction Pituitary tumours are rare; for example, the annual incidence of non-functioning pituitary adenomas is 0.65–2.34 per 100,000 ( 1 , 2 , 3 ). Although most pituitary tumours are benign, patients often need to undergo surgery and

Open access

Stefan Schulz, Anika Mann, Benjamin Novakhov, Hugh D Piggins and Amelie Lupp

tumours, including breast, ovarian, prostate, pancreas and colon carcinomas, insulinoma, carcinoid, glioblastoma, meningioma, pituitary adenoma and pheochromocytoma (4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14) . More recent studies have shown that VIP